James A. Robinson Jr. - 02 Oct 2023 Form 4 Insider Report for Eledon Pharmaceuticals, Inc. (ELDN)

Role
Director
Signature
/s/ Paul Little, as attorney-in-fact for James Robinson
Issuer symbol
ELDN
Transactions as of
02 Oct 2023
Transactions value $
$233,177
Form type
4
Filing time
03 Oct 2023, 16:19:12
Previous filing
02 Oct 2023
Next filing
08 Aug 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELDN Stock Option (Right to Buy) Award $233K +150K $1.55 150K 02 Oct 2023 Common Stock 150K $1.55 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option represents a right to purchase up to 150,437 shares of Common Stock, which option vests with respect to 75,219 shares on October 2, 2024 and with respect to 75,218 shares on October 2, 2025.